Incorporation of short wood fillers such as wood flour (WF) into polypropylene (PP) often results in a marked reduction of toughness, which is one of the main shortcomings for WF/PP composites. This research reports a facile approach to achieve toughening of WF/PP composites via introducing self-assembling β-nucleating agents into PP matrix. The effect of two kinds of nucleating agents, an aryl amide derivative (TMB5) and a rare earth complex (WBG II), at varying concentrations on the crystallization and mechanical properties of WF/PP composites was comparatively investigated. The results showed that both nucleating agents were highly effective in inducing β-crystal for WF/PP, with β-crystal content (kβ) value reaching 0.8 at 0.05 wt% nucleating agent concentration. The incorporation of TMB or WBG significantly decreased the spherulite size, increased the crystallization temperature and accelerated the crystallization process of WF/PP. As a result of PP crystalline modification, the toughness of composites was significantly improved. Through introducing 0.3 wt% TMB or WBG, the notched impact strength and strain at break of WF/PP increased by approximately 28% and 40%, respectively. Comparatively, although WF/PP-WBG had slightly higher Kβ value than WF/PP-TMB at the same concentration, WF/PP/TMB exhibited more uniform crystalline morphology with smaller spherulites. Furthermore, the tensile strength and modulus of WF/PP-TMB were higher than WF/PP-WBG. This matrix crystalline modification strategy provides a promising route to prepare wood filler/thermoplastic composites with improved toughness and accelerated crystallization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.